ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Mass General Brigham logo

Mass General Brigham

Status

Enrolling

Conditions

Major Depressive Disorder
Traumatic Brain Injury
Attention Deficit Hyperactivity Disorder
Borderline Personality Disorder
Schizophrenia
Bipolar Disorder
Substance Use Disorders

Treatments

Device: Transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04296604
2014P001428

Details and patient eligibility

About

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.

Full description

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain. The investigators will select 8 relevant diagnostic categories: traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorder. The study will also include a cohort of healthy controls for comparison.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  1. Male and female outpatients 18-65 years of age
  2. A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.

Exclusion Criteria

  1. Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy.

  2. Active substance dependence (except for tobacco and cannabis).

  3. Pregnant or nursing females.

  4. Inability to participate in testing procedures.

  5. Additional exclusion criteria for healthy controls:

    1. Diagnosis of psychiatric of neurological disorder
    2. Ongoing treatment with any psychotropic medications.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

600 participants in 8 patient groups

Traumatic Brain Injury
Experimental group
Description:
This group consists of individuals diagnosed with traumatic brain injury. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Major Depressive Disorder
Experimental group
Description:
This group consists of individuals diagnosed with major depressive disorder. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Bipolar Disorder
Experimental group
Description:
This group consists of individuals diagnosed with bipolar disorder. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Schizophrenia
Experimental group
Description:
This group consists of individuals diagnosed with schizophrenia. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Attention Deficit Hyperactivity Disorder
Experimental group
Description:
This group consists of individuals diagnosed with attention deficit hyperactivity disorder. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Borderline Personality Disorder
Experimental group
Description:
This group consists of individuals diagnosed with borderline personality disorder. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Substance Use Disorder
Experimental group
Description:
This group consists of individuals diagnosed with substance use disorder. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation
Healthy Controls
Active Comparator group
Description:
This group consists of individuals diagnosed with healthy controls. This group will undergo three sessions of tDCS: two active sessions and one sham session. The order of the sessions is randomized.
Treatment:
Device: Transcranial Direct Current Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Patricia Cirillo, MD, PhD; Joan Camprodon, MD, PhD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems